Literature DB >> 19399584

Antizyme and antizyme inhibitor, a regulatory tango.

Chaim Kahana1.   

Abstract

The polyamines are small basic molecules essential for cellular proliferation and viability. An autoregulatory circuit that responds to the intracellular level of polyamines regulates their production. In the center of this circuit is a family of small proteins termed antizymes. Antizymes are themselves regulated at the translational level by the level of polyamines. Antizymes bind ornithine decarboxylase (ODC) subunits and target them to ubiquitin-independent degradation by the 26S proteasome. In addition, antizymes inhibit polyamine transport across the plasma membrane via an as yet unresolved mechanism. Antizymes may also interact with and target degradation of other growth-regulating proteins. An inactive ODC-related protein termed antizyme inhibitor regulates polyamine metabolism by negating antizyme functions. The ability of antizymes to degrade ODC, inhibit polyamine uptake and consequently suppress cellular proliferation suggests that they act as tumor suppressors, while the ability of antizyme inhibitors to negate antizyme function indicates their growth-promoting and oncogenic potential.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19399584     DOI: 10.1007/s00018-009-0033-3

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  115 in total

Review 1.  Regulation of cellular polyamines by antizyme.

Authors:  P Coffino
Journal:  Nat Rev Mol Cell Biol       Date:  2001-03       Impact factor: 94.444

2.  Regulated degradation of ornithine decarboxylase requires interaction with the polyamine-inducible protein antizyme.

Authors:  X Li; P Coffino
Journal:  Mol Cell Biol       Date:  1992-08       Impact factor: 4.272

3.  Characterization of sequences involved in mediating degradation of ornithine decarboxylase in cells and in reticulocyte lysate.

Authors:  Y Rosenberg-Hasson; Z Bercovich; C Kahana
Journal:  Eur J Biochem       Date:  1991-03-28

4.  The mechanisms of ornithine decarboxylase deregulation in c-Ha-ras oncogene-transformed NIH 3T3 cells.

Authors:  E Hölttä; L Sistonen; K Alitalo
Journal:  J Biol Chem       Date:  1988-03-25       Impact factor: 5.157

Review 5.  Role of polyamines and their antimetabolites in clinical medicine.

Authors:  J Jänne; E Hölttä; A Kallio; K Käpyaho
Journal:  Spec Top Endocrinol Metab       Date:  1983

6.  Reduction of ornithine decarboxylase antizyme (ODC-Az) level in the 7,12-dimethylbenz(a)anthracene-induced hamster buccal pouch carcinogenesis model.

Authors:  T Tsuji; R Todd; C Meyer; J McBride; P H Liao; M F Huang; M Y Chou; R B Donoff; D T Wong
Journal:  Oncogene       Date:  1998-07-02       Impact factor: 9.867

7.  Prevention of rapid intracellular degradation of ODC by a carboxyl-terminal truncation.

Authors:  L Ghoda; T van Daalen Wetters; M Macrae; D Ascherman; P Coffino
Journal:  Science       Date:  1989-03-17       Impact factor: 47.728

8.  Structural elements of antizymes 1 and 2 are required for proteasomal degradation of ornithine decarboxylase.

Authors:  Hui Chen; Alasdair MacDonald; Philip Coffino
Journal:  J Biol Chem       Date:  2002-09-30       Impact factor: 5.157

9.  Antizyme and antizyme inhibitor activities influence cellular responses to polyamine analogs.

Authors:  J L A Mitchell; T K Thane; J M Sequeira; L J Marton; R Thokala
Journal:  Amino Acids       Date:  2007-04-06       Impact factor: 3.520

10.  The nucleic acid-binding zinc finger protein of potato virus M is translated by internal initiation as well as by ribosomal frameshifting involving a shifty stop codon and a novel mechanism of P-site slippage.

Authors:  A Gramstat; D Prüfer; W Rohde
Journal:  Nucleic Acids Res       Date:  1994-09-25       Impact factor: 16.971

View more
  37 in total

1.  A polymorphism that delays fibrosis in hepatitis C promotes alternative splicing of AZIN1, reducing fibrogenesis.

Authors:  Andrew J Paris; Zohar Snapir; Cindy D Christopherson; Shirley Y Kwok; Ursula E Lee; Zahra Ghiassi-Nejad; Peri Kocabayoglu; John J Sninsky; Josep M Llovet; Chaim Kahana; Scott L Friedman
Journal:  Hepatology       Date:  2011-12       Impact factor: 17.425

2.  Antizyme affects cell proliferation and viability solely through regulating cellular polyamines.

Authors:  Zippi Bercovich; Zohar Snapir; Alona Keren-Paz; Chaim Kahana
Journal:  J Biol Chem       Date:  2011-08-10       Impact factor: 5.157

Review 3.  Current status of the polyamine research field.

Authors:  Anthony E Pegg; Robert A Casero
Journal:  Methods Mol Biol       Date:  2011

4.  Polyamine-independent Expression of Caenorhabditis elegans Antizyme.

Authors:  Dirk Stegehake; Marc-André Kurosinski; Sabine Schürmann; Jens Daniel; Kai Lüersen; Eva Liebau
Journal:  J Biol Chem       Date:  2015-06-01       Impact factor: 5.157

5.  Targeting the aryl hydrocarbon receptor/polyamine biosynthesis axis of evil for cancer therapy.

Authors:  Robert A Casero
Journal:  J Clin Invest       Date:  2018-09-10       Impact factor: 14.808

6.  Say what? The activity of the polyamine biosynthesis inhibitor difluoromethylornithine in chemoprevention is a result of reduced thymidine pools?

Authors:  Robert A Casero
Journal:  Cancer Discov       Date:  2013-09       Impact factor: 39.397

7.  Recoding RNA editing of AZIN1 predisposes to hepatocellular carcinoma.

Authors:  Leilei Chen; Yan Li; Chi Ho Lin; Tim Hon Man Chan; Raymond Kwok Kei Chow; Yangyang Song; Ming Liu; Yun-Fei Yuan; Li Fu; Kar Lok Kong; Lihua Qi; Yan Li; Na Zhang; Amy Hin Yan Tong; Dora Lai-Wan Kwong; Kwan Man; Chung Mau Lo; Si Lok; Daniel G Tenen; Xin-Yuan Guan
Journal:  Nat Med       Date:  2013-01-06       Impact factor: 53.440

8.  Novel interaction of ornithine decarboxylase with sepiapterin reductase regulates neuroblastoma cell proliferation.

Authors:  Ingo Lange; Dirk Geerts; David J Feith; Gabor Mocz; Jan Koster; André S Bachmann
Journal:  J Mol Biol       Date:  2013-10-01       Impact factor: 5.469

Review 9.  The antizyme family for regulating polyamines.

Authors:  Chaim Kahana
Journal:  J Biol Chem       Date:  2018-10-24       Impact factor: 5.157

Review 10.  Targeting polyamine metabolism for cancer therapy and prevention.

Authors:  Tracy R Murray-Stewart; Patrick M Woster; Robert A Casero
Journal:  Biochem J       Date:  2016-10-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.